We can't find the internet
Attempting to reconnect
18543.1 PFLS-LS
Allosteric modulators of TrkB, a neuroprotective receptor: advancing compounds towards clinical candidate phase
Zusammenfassung
Allosteric modulators of TrkB, a neuroprotective receptor: advancing compounds towards clinical candidate phase
Weitere Texte
Abstract
Addex has identified novel small molecules, which are positive allosteric modulators of the neuroprotective receptor TrkB. These compounds, which have a major potential for the treatment of neurodegenerative diseases (e.g. Huntington¿s disease and amyotrophic lateral sclerosis) will be profiled in unique assays developed by the Krause group at University of Geneva. The results obtained will enable the prioritization of compounds for later stages of preclinical development.
Beteiligte
Tim Dyer
Wirtschaftspartner
Tim.Dyer@addexpharma.com
Addex Pharmaceuticals SA Tim Dyer Chemin des Aulx 12 1228 Plan-les-Ouates GE CH
Karl-Heinz Krause
Kontaktperson
karl-heinz.krause@unige.ch
Université de Genève Karl-Heinz Krause Rue Michel Servet 1 1211 Genève GE CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2016-12-31
- Enddatum
- 2019-03-31
- Bewilligte Gesamtkosten
- CHF 440762.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T490 Biotechnology 100.0%